Rain Oncology
CA - NewarkBiotechnology
Focus: Rain Oncology is an early-stage oncology-focused biotech company specializing in small molecule therapeutics, publicly traded but with limited commercial infrastructure. The company operates from Newark, CA with a portfolio spanning solid tumors, breast cancer, and lung cancer indications.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Rain Oncology
AI assessmentNot HiringNo open roles listed right now. Follow Rain Oncology to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Placebo
Cardiac RepolarizationClinical Trials (1)
NCT05758818A Study of Milademetan Administration on Cardiac Repolarization in Healthy Subjects
Phase 1Help build intelligence for Rain Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.